Showing 141 - 160 results of 471 for search '(( 10 (((peter OR per) decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 6 b decrease ))*', query time: 0.21s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145

    Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey by Turner, Stuart J.

    Published 2013
    “…Univariate sensitivity analysis highlighted that increasing the duration of voriconazole by >1.2 days or decreasing LAmB by >1.0 days changes the result. Monte Carlo Simulation resulted in 69.4% of simulations favouring voriconazole per patient treated.Conclusion: There is a strong likelihood that voriconazole is economically more favourable than LAmB in the empiric treatment of IFI in Turkey.…”
    Get full text
    Get full text
  6. 146

    Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial by El Hajj, Maguy

    Published 2015
    “…Secondary outcomes constitute quality-of-life adjustment as well as cost analysis of program resources consumed, including per case and patient outcome. Discussion: If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease the smoking burden. …”
    Get full text
    Get full text
  7. 147
  8. 148
  9. 149

    Bone benefits of fish oil supplementation depend on its EPA and DHA content by Abou-Saleh H.

    Published 2019
    “…Further, CFO supplementation was associated with an increase in the production of IL-10, IL-12, and IFN-γ and a decrease in the production of TNF-α and IL-6, and the activation of NF-κB, p38 MAPK, and JNK signaling pathways. …”
    Get full text
    Get full text
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160